Xiaowu Li

817 total citations
26 papers, 618 citations indexed

About

Xiaowu Li is a scholar working on Surgery, Oncology and Hepatology. According to data from OpenAlex, Xiaowu Li has authored 26 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Oncology and 8 papers in Hepatology. Recurrent topics in Xiaowu Li's work include Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Xiaowu Li is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Xiaowu Li collaborates with scholars based in China, United States and Australia. Xiaowu Li's co-authors include Yin Zongyi, Joseph A. Regezi, Amha Atakilit, Dongmin Dang, Daniel M. Ramos, Brian L. Schmidt, Richard C. Jordan, Shuguang Wang, Jianwei Li and Wei Liu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Xiaowu Li

25 papers receiving 612 citations

Peers

Xiaowu Li

ONCOL

PRM

HEPAT

Fumitaka Numa Japan

Mikio Monji Japan

Colby A. Wyatt United States

Trudy Jonges Netherlands

Anju Gupta India

Mordehay Klepfish Israel

S. Bhattacharya United States

Nick G. Costouros United States

Fabien Gay France

Florencia G. Jalikis United States

Fumitaka Numa Japan

Xiaowu Li

361 ×1.4

165 ×0.8

ONCOL

198 ×1.1

57 ×0.4

PRM

30 ×0.2

HEPAT

Citations per year, relative to Xiaowu Li Xiaowu Li (= 1×) peers Fumitaka Numa

Countries citing papers authored by Xiaowu Li

Since Specialization

Citations

This map shows the geographic impact of Xiaowu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowu Li more than expected).

Fields of papers citing papers by Xiaowu Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowu Li. The network helps show where Xiaowu Li may publish in the future.

Co-authorship network of co-authors of Xiaowu Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowu Li. A scholar is included among the top collaborators of Xiaowu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowu Li. Xiaowu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Xiaowu, et al.. (2025). Global burden on drug use disorders from 1990 to 2021 and projections to 2046. Frontiers in Public Health. 13. 1550518–1550518. 1 indexed citations

Fan, Jia, Jian Zhou, Xiaoyong Huang, et al.. (2024). A single-arm, multi-center phase II study of tislelizumab combined with lenvatinib and GEMOX as conversion therapy in potentially resectable locally advanced biliary tract cancer (ZSAB-TransGOLP): A primary analysis.. Journal of Clinical Oncology. 42(3_suppl). 488–488. 1 indexed citations

Zongyi, Yin, et al.. (2022). Neoadjuvant Therapy for Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. Volume 9. 929–946. 23 indexed citations

Kim, Jua, Yin Zongyi, Chu‐Xia Deng, et al.. (2021). Expansion of Rare Cancer Cells into Tumoroids for Therapeutic Regimen and Cancer Therapy. Advanced Therapeutics. 4(7). 6 indexed citations

Wei, Xiaolin, Wenjing Zheng, Hui Liu, et al.. (2020). Administration of glycyrrhetinic acid reinforces therapeutic effects of mesenchymal stem cell‐derived exosome against acute liver ischemia‐reperfusion injury. Journal of Cellular and Molecular Medicine. 24(19). 11211–11220. 21 indexed citations

Li, Xiaowu. (2020). Immunotherapy for Hepatocellular Carcinoma. 4(1). 1 indexed citations

Zongyi, Yin & Xiaowu Li. (2019). Immunotherapy for hepatocellular carcinoma. Cancer Letters. 470. 8–17. 187 indexed citations

Yuan, Yuan, et al.. (2019). Sotrastaurin attenuates the stemness of gastric cancer cells by targeting PKCδ. Biomedicine & Pharmacotherapy. 117. 109165–109165. 16 indexed citations

Wei, Xiaolin, et al.. (2019). Effect of the intermittent Pringle maneuver on liver damage after hepatectomy: a retrospective cohort study. World Journal of Surgical Oncology. 17(1). 142–142. 22 indexed citations

10.

Wei, Xiaolin, et al.. (2019). MicroRNA-125a-3p overexpression promotes liver regeneration through targeting proline-rich acidic protein 1. Annals of Hepatology. 19(1). 99–106. 7 indexed citations

11.

Li, Xiaowu, Hongrong Liu, & Lingpeng Cheng. (2016). Symmetry-mismatch reconstruction of genomes and associated proteins within icosahedral viruses using cryo-EM. Biophysics Reports. 2(1). 25–32. 17 indexed citations

12.

Li, Yong, Dajiang Li, Wei Liu, et al.. (2015). Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma. Asian Pacific Journal of Cancer Prevention. 16(8). 3451–3455. 54 indexed citations

13.

Zhang, Fan, Jun Yan, Xiaobin Feng, et al.. (2015). Efficiency and safety of radiofrequency-assisted hepatectomy for hepatocellular carcinoma with cirrhosis: A single-center retrospective cohort study. World Journal of Gastroenterology. 21(35). 10159–10165. 6 indexed citations

14.

Chen, Kai, Zhonghu Li, Peng Jiang, et al.. (2014). CD44, CD133 and TF correlate with formation of portal vein tumor thrombus and poor prognosis in patients with hepatocellular carcinoma. 36(10). 1068–1073. 3 indexed citations

15.

Tian, Feng, Dajiang Li, Jian Chen, et al.. (2013). Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma. European Journal of Cancer. 49(7). 1771–1780. 32 indexed citations

16.

Tian, Feng, Long Cheng, Dajiang Li, et al.. (2011). Downregulation of Mucins in Graft Bile Ducts After Liver Transplantation in Rats. Transplantation. 92(5). 529–535. 10 indexed citations

17.

Dang, Dongmin, Xiaowu Li, Amha Atakilit, et al.. (2004). Matrix metalloproteinases and TGFβ1 modulate oral tumor cell matrix. Biochemical and Biophysical Research Communications. 316(3). 937–942. 41 indexed citations

18.

Dang, Dongmin, Amha Atakilit, Brian L. Schmidt, et al.. (2003). Specific αv integrin receptors modulate K1735 murine melanoma cell behavior. Biochemical and Biophysical Research Communications. 308(4). 814–819. 11 indexed citations

19.

Ramos, Daniel M., Joseph A. Regezi, Brian L. Schmidt, et al.. (2002). Expression of integrin β6 enhances invasive behavior in oral squamous cell carcinoma. Matrix Biology. 21(3). 297–307. 110 indexed citations

20.

Yan, Lünan, et al.. (1997). Redox tolerance test: An indicator of preoperative hepatic functional reserve in liver diseases. Journal of Hepato-Biliary-Pancreatic Surgery. 4(3). 249–253. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact